Abbott MediaRoom Abbott Declares 377th Consecutive Quarterly Dividend Fri, 16 Feb 2018 11:20:00 -0500 Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™ -- FREESTYLE LIBRELINK[1],[2] APP ENABLES FREESTYLE LIBRE USERS TO MONITOR THEIR GLUCOSE DIRECTLY WITH THEIR SMARTPHONE Wed, 07 Feb 2018 09:00:00 -0500 Abbott Reports Fourth-Quarter 2017 Results - Fourth-quarter reported sales growth of 42.3 percent; comparable operational sales growth of 7.7 percent Wed, 24 Jan 2018 07:45:00 -0500 Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients - CMS reimbursement provides opportunity for Medicare patients who meet eligibility criteria to access FreeStyle Libre System Thu, 04 Jan 2018 09:00:00 -0500 New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices - New MR-conditional labeling for two of the company’s most widely-used high voltage devices continue cadence of MRI approvals within Abbott’s cardiac rhythm management portfolio Wed, 03 Jan 2018 09:00:00 -0500